TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624959. A total of 5 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,014 | +118.4% | 981,800 | +61.2% | 0.13% | +97.0% |
| Q2 2023 | $4,586 | -21.1% | 609,000 | -7.2% | 0.07% | -30.9% |
| Q1 2023 | $5,811 | -51.6% | 656,600 | -50.2% | 0.10% | -63.7% |
| Q4 2022 | $12,016 | -99.9% | 1,317,500 | -18.8% | 0.27% | -6.3% |
| Q3 2022 | $13,094,000 | -2.2% | 1,622,600 | -8.8% | 0.28% | -2.7% |
| Q2 2022 | $13,384,000 | -36.5% | 1,779,800 | -20.7% | 0.29% | -1.3% |
| Q1 2022 | $21,082,000 | +52.1% | 2,245,200 | +29.7% | 0.30% | +65.9% |
| Q4 2021 | $13,865,000 | +24.9% | 1,731,000 | +55.4% | 0.18% | +20.1% |
| Q3 2021 | $11,103,000 | +53.5% | 1,113,600 | +52.4% | 0.15% | +26.3% |
| Q2 2021 | $7,232,000 | +85.4% | 730,500 | +116.1% | 0.12% | +90.3% |
| Q1 2021 | $3,901,000 | -9.8% | 338,000 | -24.6% | 0.06% | +21.6% |
| Q4 2020 | $4,324,000 | -25.7% | 448,100 | -28.5% | 0.05% | -43.3% |
| Q3 2020 | $5,821,000 | +17.0% | 626,600 | +55.3% | 0.09% | -28.6% |
| Q2 2020 | $4,976,000 | +53.4% | 403,600 | +21.9% | 0.13% | +1.6% |
| Q4 2019 | $3,244,000 | +59.3% | 331,000 | +11.8% | 0.12% | +34.8% |
| Q3 2019 | $2,036,000 | +3.1% | 296,000 | +38.4% | 0.09% | +1.1% |
| Q2 2019 | $1,974,000 | -3.2% | 213,900 | +64.4% | 0.09% | -20.9% |
| Q1 2019 | $2,040,000 | – | 130,100 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Markets Trading UK LLP | 2,245,200 | $21,082,000 | 0.30% |
| GROUP ONE TRADING, L.P. | 4,396,500 | $41,283,000 | 0.04% |
| SIMPLEX TRADING, LLC | 1,490,700 | $13,997,000 | 0.01% |
| IMC-Chicago, LLC | 439,500 | $4,127,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |